Anest. intenziv. Med. 2008;19(4):218-225

Treatment of acute heart failure syndrome - reviewIntesive Care Medicine - Review Article

Kettner Jiří
Klinika kardiologie, IKEM, Praha

Acute heart failure syndromes comprises a heterogenous set of conditions associated with a high mortality and hospitalizations rates and a consequent heavy healthcare burden. Initial therapy in patients with acute heart failure should be directed at improving symptoms and patient haemodynamics. The evidence base for many traditional therapies is weak, and, in some cases, short-term benefits are gained at the expense of long-term outcomes. This paper summarizes current basic pharmacological and non-pharmacological management of patients with acute heart failure syndromes.

Keywords: acute heart failure; management of heart failure; vasodilators; inotropes; ventricular assist devices

Received: May 6, 2008; Accepted: June 12, 2008; Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kettner J. Treatment of acute heart failure syndrome - review. Anest. intenziv. Med. 2008;19(4):218-225.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nieminen, M. S., Boehm, M., Cowie, M. R. et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur. Heart J., 2005, 26, p. 383-416. Go to original source... Go to PubMed...
    2. American Heart Association Heart Disease and Stroke Statistics - 2004 Update. Dallas, TX : American Heart Association, 2003.
    3. Stevenson, R.,Ranjadayalan, K., Wilkinson, P. et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br. Med. J., 1993, 307, p. 349-353. Go to original source... Go to PubMed...
    4. Roguin, A., Behar, D., Ben Ami, H. et al. Long-term prognosis of acute pulmonary oedema - an ominous outcome. Eur. J. Heart Fail., 2000, 2, p. 137-144. Go to original source... Go to PubMed...
    5. Krumholz, H. M., Parent, E. M., Tu, N. et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch. Intern. Med., 1997, 157, p. 99-104. Go to original source...
    6. Špinar, J., Janský, P., Kettner, J. et al. Doporučení pro diagnostiku a léčbu akutního srdečního selhání. CorVasa, 2006, 48, p. K3-31.
    7. Chen, C. H., Nakayama, M., Nevo, E. et al. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J. Am. Coll. Cardiol., 1998, 32, p. 1221-1227. Go to original source... Go to PubMed...
    8. Cotter, G., Metzkor, E., Kaluski, E. et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet, 1998, 351, 9100, p. 389-393. Go to original source... Go to PubMed...
    9. Narula, J., Haider, N., Virmani, R. et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med., 1996, 335, p. 1182-1189. Go to original source... Go to PubMed...
    10. Thackray, S., Easthaugh, J., Freemantle, N. et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur. J. Heart Fail., 2002, 4, p. 515-529. Go to original source... Go to PubMed...
    11. Lowes, B. D., Tsvetkova, T., Eichhorn, E. J. et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int. J. Cardiol., 2001, 81, p. 141-149. Go to original source... Go to PubMed...
    12. Felker, G. M., Benza, R. L., Chandler, A. B. et al. Heart failure etiology and response to milrinone in decompensated heart failure. Results from the OPTIME-CHF Study. JACC, 2003, 41, p. 997-1003. Go to original source... Go to PubMed...
    13. Kivikko, M., Lehtonen, L., Colucci, W. S. Sustained hemodynamic effects of intravenous levosimendan. Circulation, 2003, 107, p. 81-86. Go to original source... Go to PubMed...
    14. Innes, C. A., Wagstaff, A. J. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs, 2003, 63, p. 2651-2671. Go to original source... Go to PubMed...
    15. Kivikko, M., Antila, S., Eha, J. et al. Pharmacokinetics of levosimendan and its metabolites during and after a 24 h continuous infusion in patients with severe heart failure. Int. J. Clin. Pharmacol. Ther., 2002, 40, p. 465-471. Go to original source... Go to PubMed...
    16. Follath, F., Cleland, J. G. F., Just, H. et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double blind study. Lancet, 2002, 360, p. 196-202. Go to original source... Go to PubMed...
    17. Moiseyev, V. S., Poder, P., Andrejevs, N. et al. Safety and efficacy of a novel calcium sensitiser, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomised, placebo-controlled, double blind study (RUSSLAN). Eur. Heart J., 2002, 23, p. 132-142. Go to original source... Go to PubMed...
    18. Zairis, M. N., Apostolatos, C., Anastassiadis, F. et al. Comparison of the effect of levosimendan, or dobutamin or placebo in chronic low output decompensated heart failure. Calcium Sensitizer or Inotrope or None in low output heart failure (CASINO) study. Eur. J. Heart Fail., 2004, 3, Suppl. 1, 66, abstract 273. Go to original source...
    19. Mebazaa, A., Nieminen, M. S., Packer, M., Cohen-Solal, A., Kleber, F. X., Pocock, S. J., Thakkar, R., Padley, R. J., Põder, P., Kivikko, M., SURVIVE Investigators Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA, 2007, 297, p. 1883-1891. Go to original source... Go to PubMed...
    20. Yamani, M. H., Haji, S. A., Starling, R. C. et al. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. Am. Heart J., 2001, 142, p. 998-1002. Go to original source... Go to PubMed...
    21. Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST Segment Elevation Acute Coronary Syndrome of the European Society of Cardiology. Eur. Heart J., 2007, 28, p. 1598-1660.
    22. Samama, M. M., Cohen, A. T., Darmon, J. Y. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N. Engl. J. Med., 1999, 341, p. 793-800. Go to original source... Go to PubMed...
    23. deGoma, E. M., Vagelos, R. H., Fowler, M. B. et al. Emerging therapies for the management of decompensated heart failure. J. Am. Coll. Cardiol., 2006, 48, p. 2397-2409. Go to original source... Go to PubMed...
    24. Liesching, T., Kwok, H., Hill, N. S. Acute applications of noninvasive positive pressure ventilation. Chest, 2003, 124, p. 699-713. Go to original source... Go to PubMed...
    25. Peter, J. V., Moran, J. L., Phillips-Hughes, J. et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet, 2006, 367, p. 1155-1163. Go to original source... Go to PubMed...
    26. Neuberg, G. W., Miller, A. B., O'Connor, C. M. et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am. Heart J., 2002, 144, p. 31-38. Go to original source... Go to PubMed...
    27. Bellomo, R., Ronco, C. Continuous haemofiltration in the intensive care unit. Crit. Care, 2000, 4, p. 339-345. Go to original source... Go to PubMed...
    28. Costanzo, M. R., Guglin, M. E., Saltzberg, M. T. et al. For the UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J. Am. Coll. Cardiol., 2007, 49, p. 675-683. Go to original source... Go to PubMed...
    29. Kettner, J. Mechanické podpory krevního oběhu. Cor. Vasa., 2003, 45, 9, p. 437-443.
    30. Kettner, J. Mechanické srdeční podpory u závažného srdečního selhání. Postgrad Med. (mimořádná příloha), 2007, 9, p. 44-50.

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.